COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR

• 收藏
• 分享

专利权人:

发明人:

申请号：

HK13102957.2

公开号：

HK1175413A

申请日:

2013.03.11

申请国别(地区):

HK

年份:

2013

代理人:

摘要：

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a m TOR inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a mTOR inhibitor such as Temsirolimus or Everolimus.La présente invention concerne la polythérapie dun anticorps anti-CD20 afucosylé et dun inhibiteur de mTOR pour le traitement du cancer, notamment la polythérapie de cancers exprimant CD20 par un anticorps B-Ly1 humanisé afucosylé et par un inhibiteur de mTOR tel que Temsirolimus ou Everolimus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/